GENMAB

Welcome to the Brand page for “GENMAB”, which is offered here for Medical scientific research, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, aids, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, patent licensing; licensing of intellectual property in the field of medicine; computer programming, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies;.

Its status is currently believed to be active. Its class is unavailable. “GENMAB” is believed to be currently owned by “Genmab A/S”.